All In Biotech

Drug Trial Radar · NCT07498426

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

A Phase III, Randomized, Placebo-controlled, Parallel Group, Double-blind Study to Evaluate the Efficacy and Safety of NIO752 in Participants With Progressive Supranuclear Palsy Followed by an Open Label Extension

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Jun 3, 2026

Primary completion

Jul 20, 2029

Study completion Jul 18, 2031

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Mar 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 41 years, up to 81 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase III study is intended to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Eligible participants will be randomized to receive either NIO752 or placebo followed by an open-label extension.

Conditions

  • Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

Interventions

  • NIO752Other

    Solution of antisense oligonucleotide.

  • PlaceboDrug

    Placebo solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in the mPSPRS-10 scoreTime frame: Baseline, Week 72

Locations

64 sites in 12 countries. Site status is shown where the registry gives one.

  • Mayo Clinic Arizona

    Scottsdale, Arizona · Recruiting

  • Univ of California San Francisco

    San Francisco, California · Recruiting

  • CenExcel Rocky Mtn Clin Research

    Englewood, Colorado · Recruiting

  • Parkinsons Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida · Recruiting

  • Mayo Jacksonville

    Jacksonville, Florida · Recruiting

  • University of Kentucky - C201 Clinic

    Lexington, Kentucky · Recruiting

  • Ochsner Clinic Foundation

    New Orleans, Louisiana · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Central TX Neuro Consultants P A

    Round Rock, Texas · Recruiting

  • Novartis Investigative Site

    Kogarah, New South Wales, Australia · Recruiting

  • Novartis Investigative Site

    Westmead, New South Wales, Australia · Recruiting

  • Novartis Investigative Site

    Melbourne, Victoria, Australia · Recruiting

  • Novartis Investigative Site

    Bruges, Belgium · Recruiting

  • Novartis Investigative Site

    Leuven, Vlaams Brabant, Belgium · Recruiting

  • Novartis Investigative Site

    Beijing, China · Recruiting

  • Novartis Investigative Site

    Beijing, China · Recruiting

  • Novartis Investigative Site

    Jinan, China · Recruiting

  • Novartis Investigative Site

    Shanghai, China · Recruiting

  • Novartis Investigative Site

    Suzhou, China · Recruiting

  • Novartis Investigative Site

    Wuhan, China · Recruiting

  • Novartis Investigative Site

    Chengdu, Sichuan, China · Recruiting

  • Novartis Investigative Site

    Caen, France · Recruiting

  • Novartis Investigative Site

    Créteil, France · Recruiting

  • Novartis Investigative Site

    Lille, France · Recruiting

  • Novartis Investigative Site

    Marseille, France · Recruiting

  • Novartis Investigative Site

    Nantes, France · Recruiting

  • Novartis Investigative Site

    Paris, France · Recruiting

  • Novartis Investigative Site

    Rennes, France · Recruiting

  • Novartis Investigative Site

    Toulouse, France · Recruiting

  • Novartis Investigative Site

    Beelitz, Germany · Recruiting

  • Novartis Investigative Site

    Berlin, Germany · Recruiting

  • Novartis Investigative Site

    Stadtroda, Germany · Recruiting

  • Novartis Investigative Site

    Tübingen, Germany · Recruiting

  • Klinik für Neurologie (Schwerpunkt Neurodegeneration)

    Ulm, Germany · Recruiting

  • Novartis Investigative Site

    Munich, Bavaria, Germany · Recruiting

  • Novartis Investigative Site

    Würzburg, Bavaria, Germany · Recruiting

  • Novartis Investigative Site

    Bonn, North Rhine-Westphalia, Germany · Recruiting

  • Novartis Investigative Site

    Düsseldorf, North Rhine-Westphalia, Germany · Recruiting

  • Novartis Investigative Site

    Dresden, Saxony, Germany · Recruiting

  • Novartis Investigative Site

    Leipzig, Saxony, Germany · Recruiting

Showing 40 of 64 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.